Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swapnil Potdar

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 13, 2026
Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory diseaseChristina Linder-Stragliotto, Panagiotis Tsagkozis, Swapnil Potdar, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 4, 2022
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well platesMichaela Feodoroff, Piia Mikkonen, Mariliina Arjama, et al.
Iscience|October 31, 2025
Spatial artifact detection improves the reproducibility of drug screening experimentsAleksandr Ianevski, Kristen Nader, Swapnil Potdar, et al.
Nature Machine Intelligence|May 6, 2020
Prediction of drug combination effects with a minimal set of experimentsAleksandr Ianevski, Anil K Giri, Prson Gautam, et al.
NPJ Biofilms and Microbiomes|June 29, 2022
Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidumVeera Kainulainen, Carina von Schantz-Fant, Ruusu-Maria Kovanen, et al.
Translational Oncology|September 17, 2022
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcomeErlend Skaga, Evgeny Kulesskiy, Swapnil Potdar, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 19, 2023
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)Michaela Feodoroff, Piia Mikkonen, Laura Turunen, et al.
Nucleic Acids Research|February 2, 2023
P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathwayZhijia Wang, Monika Mačáková, Andrii Bugai, et al.
Nucleic Acids Research|May 13, 2023
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response dataSwapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, et al.
Acta Dermato-Venereologica|August 3, 2025
High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized SclerodermaKatariina Mähönen, Isabel Mogollon, Antti Hassinen, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 13, 2026
Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory diseaseChristina Linder-Stragliotto, Panagiotis Tsagkozis, Swapnil Potdar, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 4, 2022
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well platesMichaela Feodoroff, Piia Mikkonen, Mariliina Arjama, et al.
Iscience|October 31, 2025
Spatial artifact detection improves the reproducibility of drug screening experimentsAleksandr Ianevski, Kristen Nader, Swapnil Potdar, et al.
Nature Machine Intelligence|May 6, 2020
Prediction of drug combination effects with a minimal set of experimentsAleksandr Ianevski, Anil K Giri, Prson Gautam, et al.
NPJ Biofilms and Microbiomes|June 29, 2022
Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidumVeera Kainulainen, Carina von Schantz-Fant, Ruusu-Maria Kovanen, et al.
Translational Oncology|September 17, 2022
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcomeErlend Skaga, Evgeny Kulesskiy, Swapnil Potdar, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 19, 2023
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT)Michaela Feodoroff, Piia Mikkonen, Laura Turunen, et al.
Nucleic Acids Research|February 2, 2023
P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathwayZhijia Wang, Monika Mačáková, Andrii Bugai, et al.
Nucleic Acids Research|May 13, 2023
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response dataSwapnil Potdar, Filipp Ianevski, Aleksandr Ianevski, et al.
Acta Dermato-Venereologica|August 3, 2025
High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized SclerodermaKatariina Mähönen, Isabel Mogollon, Antti Hassinen, et al.
Pageof 4